Postmenopausal Osteoporosis

Postmenopausal osteoporosis, also called osteoporosis type I, usually develops in women after menopause. It is characterised by a sharp drop in estrogen levels. These changes lead to bone loss (decrease in bone mineral density), mostly in the trabecular (spongy) bone within the hard bone cortex. This increases the risk of bone fractures and can lead to disability or even death.

Showing all 9 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Denosumab 1078318B	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2018.11	324,00 €	view product Max: 4 Min: 1 Step: 1
Denosumab 1080147A	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2019.07	324,00 €	view product Max: 10 Min: 1 Step: 1
Denosumab 1082130A	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2019.10	324,00 €	view product Max: 5 Min: 1 Step: 1
Denosumab 1087971A	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2020.04	324,00 €	view product Max: 7 Min: 1 Step: 1
Denosumab 1090173B	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2020.09	324,00 €	view product Max: 2 Min: 1 Step: 1
Denosumab 1094444A	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2021.01	324,00 €	view product Max: 2 Min: 1 Step: 1
Denosumab 1114463	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2022.06	324,00 €	view product Max: 10 Min: 1 Step: 1
Denosumab 1115845	RANKL	Monoclonal Antibody	Prolia®	60 mg/mL	–	3 mg	-80°C	2022.10	324,00 €	view product Max: 5 Min: 1 Step: 1
Teriparatid	PTH1	Hormone	Forsteo®	0,25 mg/mL	–	0,01 mg	tba	tba	203,00 €	view product Max: 50 Min: 11 Step: 1